<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38658821</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>24</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Multimorbidity in middle-aged women and COVID-19: binary data clustering for unsupervised binning of rare multimorbidity features and predictive modeling.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-024-02200-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Multimorbidity is typically associated with deficient health-related quality of life in mid-life, and the likelihood of developing multimorbidity in women is elevated. We address the issue of data sparsity in non-prevalent features by clustering the binary data of various rare medical conditions in a cohort of middle-aged women. This study aims to enhance understanding of how multimorbidity affects COVID-19 severity by clustering rare medical conditions and combining them with prevalent features for predictive modeling. The insights gained can guide the development of targeted interventions and improved management strategies for individuals with multiple health conditions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study focuses on a cohort of 4477 female patients, (aged 45-60) in Piedmont, Italy, and utilizes their multimorbidity data prior to the COVID-19 pandemic from their medical history from 2015 to 2019. The COVID-19 severity is determined by the hospitalization status of the patients from February to May 2020. Each patient profile in the dataset is depicted as a binary vector, where each feature denotes the presence or absence of a specific multimorbidity condition. By clustering the sparse medical data, newly engineered features are generated as a bin of features, and they are combined with the prevalent features for COVID-19 severity predictive modeling.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From sparse data consisting of 174 input features, we have created a low-dimensional feature matrix of 17 features. Machine Learning algorithms are applied to the reduced sparsity-free data to predict the Covid-19 hospital admission outcome. The performance obtained for the corresponding models are as follows: Logistic Regression (accuracy 0.72, AUC 0.77, F1-score 0.69), Linear Discriminant Analysis (accuracy 0.7, AUC 0.77, F1-score 0.67), and Ada Boost (accuracy 0.7, AUC 0.77, F1-score 0.68).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Mapping higher-dimensional data to a low-dimensional space can result in information loss, but reducing sparsity can be beneficial for Machine Learning modeling due to improved predictive ability. In this study, we addressed the issue of data sparsity in electronic health records and created a model that incorporates both prevalent and rare medical conditions, leading to more accurate and effective predictive modeling. The identification of complex associations between multimorbidity and the severity of COVID-19 highlights potential areas of focus for future research, including long COVID and intervention efforts.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benny</LastName><ForeName>Dayana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, 10043, Piedmont, Italy. dayana.benny@unito.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Modeling and Data Science, Department of Mathematics, University of Turin, Via Carlo Alberto 10, Turin, 10123, Piedmont, Italy. dayana.benny@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacobini</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Data Analysis and Modeling Unit, Department of Veterinary Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, 10043, Piedmont, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Epidemiology, Regional Health Service, Local Health Unit Torino 3, Grugliasco, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnavi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Epidemiology, Regional Health Service, Local Health Unit Torino 3, Grugliasco, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricceri</LastName><ForeName>Fulvio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, 10043, Piedmont, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076322" MajorTopicYN="Y">Multimorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Binary classification</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clustering</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multimorbidity</Keyword><Keyword MajorTopicYN="N">Predictive modeling</Keyword><Keyword MajorTopicYN="N">Public health</Keyword><Keyword MajorTopicYN="N">Sparse binary data</Keyword><Keyword MajorTopicYN="N">Unsupervised binning</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38658821</ArticleId><ArticleId IdType="pmc">PMC11040796</ArticleId><ArticleId IdType="doi">10.1186/s12874-024-02200-x</ArticleId><ArticleId IdType="pii">10.1186/s12874-024-02200-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harrison C, Fortin M, van den Akker M, Mair F, Calderon-Larranaga A, Boland F, et al. Comorbidity versus multimorbidity: why it matters. J Multimorb Comorb. 2021;11:2633556521993993. 10.1177/2633556521993993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930649</ArticleId><ArticleId IdType="pubmed">33718251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanesarajah J, Waller M, Whitty JA, Mishra GD. Multimorbidity and quality of life at mid-life: a systematic review of general population studies. Maturitas. 2018;109:53&#x2013;62. doi: 10.1016/j.maturitas.2017.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2017.12.004</ArticleId><ArticleId IdType="pubmed">29452782</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimohammadian M, Majidi A, Yaseri M, Ahmadi B, Islami F, Derakhshan M, et al. Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West Asia. BMJ Open. 2017;7(5):e013548. doi: 10.1136/bmjopen-2016-013548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-013548</ArticleId><ArticleId IdType="pmc">PMC5623450</ArticleId><ArticleId IdType="pubmed">28490550</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy. 2016;9:143&#x2013;56. doi: 10.2147/RMHP.S97248.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S97248</ArticleId><ArticleId IdType="pmc">PMC4939994</ArticleId><ArticleId IdType="pubmed">27462182</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34(6):321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29(2):334&#x2013;343. doi: 10.1038/s41591-022-02156-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02156-9</ArticleId><ArticleId IdType="pubmed">36797482</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R, Narendran M, Bindu A, Beevi N, Manju L, Benny P. Public perception and preparedness for the pandemic COVID 19: a health belief model approach. Clin Epidemiol Glob Health. 2021;9:41&#x2013;46. doi: 10.1016/j.cegh.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7837111</ArticleId><ArticleId IdType="pubmed">33521389</ArticleId></ArticleIdList></Reference><Reference><Citation>Delerue Matos A, Fonseca de Paiva A, Cunha C, Voss G. Precautionary behaviours of individuals with multimorbidity during the COVID-19 pandemic. Eur J Ageing. 2022;19(4):827&#x2013;35. 10.1007/s10433-021-00632-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8724001</ArticleId><ArticleId IdType="pubmed">35002593</ArticleId></ArticleIdList></Reference><Reference><Citation>Benny D, Castro S, Mujahid O, Abrosimova OL. Contact tracing for COVID-19 in Ukraine: insights from a case study in the region of Chernivtsi. Reg Acad U N. 2021;8(1):1&#x2013;43. https://hdl.handle.net/2318/1887191.</Citation></Reference><Reference><Citation>Cornell JE, Pugh JA, Williams JW, Jr, Kazis L, Lee AF, Parchman ML, et al. Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database. Appl Multivar Res. 2008;12(3):163&#x2013;182. doi: 10.22329/amr.v12i3.658.</Citation><ArticleIdList><ArticleId IdType="doi">10.22329/amr.v12i3.658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghebre MA, Bafadhel M, Desai D, Cohen SE, Newbold P, Rapley L, et al. Biological clustering supports both &#x201c;Dutch&#x201d; and &#x201c;British&#x201d; hypotheses of asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2015;135(1):63&#x2013;72. doi: 10.1016/j.jaci.2014.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.06.035</ArticleId><ArticleId IdType="pmc">PMC4282726</ArticleId><ArticleId IdType="pubmed">25129678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SHX, Rahman N, Ang IYH, Sridharan S, Ramachandran S, Wang DD, et al. Characterization of high healthcare utilizer groups using administrative data from an electronic medical record database. BMC Health Serv Res. 2019;19(1):1&#x2013;14. doi: 10.1186/s12913-019-4239-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4239-2</ArticleId><ArticleId IdType="pmc">PMC6612067</ArticleId><ArticleId IdType="pubmed">31277649</ArticleId></ArticleIdList></Reference><Reference><Citation>Viol&#xe1;n C, Roso-Llorach A, Foguet-Boreu Q, Guisado-Clavero M, Pons-Vigu&#xe9;s M, Pujol-Ribera E, et al. Multimorbidity patterns with K-means nonhierarchical cluster analysis. BMC Fam Pract. 2018;19:1&#x2013;11. doi: 10.1186/s12875-018-0790-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-018-0790-x</ArticleId><ArticleId IdType="pmc">PMC6031109</ArticleId><ArticleId IdType="pubmed">29969997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretos-Azcona PE, S&#xe1;nchez-Iriso E, Cabas&#xe9;s Hita JM. Tailoring integrated care services for high-risk patients with multiple chronic conditions: a risk stratification approach using cluster analysis. BMC Health Serv Res. 2020;20:1&#x2013;9. doi: 10.1186/s12913-020-05668-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05668-7</ArticleId><ArticleId IdType="pmc">PMC7451239</ArticleId><ArticleId IdType="pubmed">32854694</ArticleId></ArticleIdList></Reference><Reference><Citation>Benny D, Soumya KR, Rao KN. New Dynamic Self-organizing Feature maps for the classification of Extracted Feature vectors of characters. In: 2015 International Conference on Robotics, Automation, Control and Embedded Systems (RACE). IEEE; 2015. p. 1&#x2013;3. 10.1109/RACE.2015.7097273.</Citation></Reference><Reference><Citation>Khalilia MA, Popescu M, Keller J, Patient stratification based on activity of daily living score using relational self-organizing maps. In: 2014 IEEE Symposium on Computational Intelligence in Healthcare and e-health (CICARE). IEEE; 2014. p. 112&#x2013;6.</Citation></Reference><Reference><Citation>Catalano A, Dansero L, Gilcrease W, Macciotta A, Saugo C, Manfredi L, et al. Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients. JMIR Public Health Surveill. 2023;9(1):e41404. doi: 10.2196/41404.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/41404</ArticleId><ArticleId IdType="pmc">PMC9951075</ArticleId><ArticleId IdType="pubmed">36626821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Li T, Ding C, Zhang X. Binary matrix factorization with applications. In: Seventh IEEE international conference on data mining (ICDM 2007). IEEE; 2007. p. 391&#x2013;400.</Citation></Reference><Reference><Citation>Belohlavek R, Vychodil V. Discovery of optimal factors in binary data via a novel method of matrix decomposition. J Comput Syst Sci. 2010;76(1):3&#x2013;20. doi: 10.1016/j.jcss.2009.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcss.2009.05.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T. A general model for clustering binary data. In: Proceedings of the eleventh ACM SIGKDD international conference on Knowledge discovery in data mining (KDD '05).&#xa0;New York: Association for Computing Machinery; 2005. p. 188&#x2013;197. 10.1145/1081870.1081894.</Citation></Reference><Reference><Citation>Benny D, Soumya KR. New local adaptive thresholding and dynamic self-organizing feature map techniques for handwritten character recognizer. In: 2015 International Conference on Circuits, Power and Computing Technologies [ICCPCT-2015]. IEEE; 2015. p. 1&#x2013;4. 10.1109/ICCPCT.2015.7159293.</Citation></Reference><Reference><Citation>Ali M. (2022, April). PyCaret: An open source, low-code machine learning library in Python [PyCaret version 2.3.10]. https://pycaret.org/.</Citation></Reference><Reference><Citation>Pycaret. Feature Selection - Docs. Pycaret. https://pycaret.gitbook.io/docs/get-started/preprocessing/feature-selection. Accessed 30 Jan 2023.</Citation></Reference><Reference><Citation>Jia W, Sun M, Lian J, Hou S. Feature dimensionality reduction: a review. Complex Intell Syst. 2022;8(3):2663&#x2013;2693. doi: 10.1007/s40747-021-00637-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40747-021-00637-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S, Patil A, Phalle VM. Life prediction of bearing by using adaboost regressor. In: Proceedings of International Conference on Tribology [TRIBOINDIA-2018], Mumbai, India. 10.2139/ssrn.3398399. Available at: SSRN 3398399.</Citation></Reference><Reference><Citation>Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30. p. 4765&#x2013;74. https://papers.nips.cc/paper/7062-a-unified-approach-to-interpreting-model-predictions.pdf.</Citation></Reference><Reference><Citation>Pivonello R, Auriemma RS, Pivonello C, Isidori AM, Corona G, Colao A, et al. Sex disparities in COVID-19 severity and outcome: are men weaker or women stronger? Neuroendocrinology. 2021;111(11):1066&#x2013;1085. doi: 10.1159/000513346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513346</ArticleId><ArticleId IdType="pmc">PMC7900484</ArticleId><ArticleId IdType="pubmed">33242856</ArticleId></ArticleIdList></Reference><Reference><Citation>Stillwell RC. Exclusion of women from COVID-19 studies harms women&#x2019;s health and slows our response to pandemics. Biol Sex Differ. 2022;13(1):27. doi: 10.1186/s13293-022-00435-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-022-00435-1</ArticleId><ArticleId IdType="pmc">PMC9175518</ArticleId><ArticleId IdType="pubmed">35676733</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith DM, Sharma G, Holliday CS, Enyia OK, Valliere M, Semlow AR, et al. Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Prev Chronic Dis. 2020;17:E63. doi: 10.5888/pcd17.200247.</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd17.200247</ArticleId><ArticleId IdType="pmc">PMC7380297</ArticleId><ArticleId IdType="pubmed">32678061</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins JL, Masoli JA, Delgado J, Pilling LC, Kuo CL, Kuchel GA, et al. Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontol Ser A. 2020;75(11):2224&#x2013;2230. doi: 10.1093/gerona/glaa183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa183</ArticleId><ArticleId IdType="pmc">PMC7454409</ArticleId><ArticleId IdType="pubmed">32687551</ArticleId></ArticleIdList></Reference><Reference><Citation>Dror AA, Morozov N, Daoud A, Namir Y, Yakir O, Shachar Y, et al. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. PLoS ONE. 2022;17(2):e0263069. doi: 10.1371/journal.pone.0263069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263069</ArticleId><ArticleId IdType="pmc">PMC8812897</ArticleId><ArticleId IdType="pubmed">35113901</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlando V, Coscioni E, Guarino I, Mucherino S, Perrella A, Trama U, et al. Drug-utilisation profiles and COVID-19. Sci Rep. 2021;11(1):8913. doi: 10.1038/s41598-021-88398-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88398-y</ArticleId><ArticleId IdType="pmc">PMC8076316</ArticleId><ArticleId IdType="pubmed">33903671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzsa R, Benk&#x151; R, Hambalek H, Papfalvi E, Csupor D, Nacsa R, et al. Hospital Antibiotic Consumption before and during the COVID-19 Pandemic in Hungary. Antibiotics. 2024;13(1):102. doi: 10.3390/antibiotics13010102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13010102</ArticleId><ArticleId IdType="pmc">PMC10812576</ArticleId><ArticleId IdType="pubmed">38275331</ArticleId></ArticleIdList></Reference><Reference><Citation>Maclure KM, Hayes K, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med. 1989;321(9):563&#x2013;569. doi: 10.1056/NEJM198908313210902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198908313210902</ArticleId><ArticleId IdType="pubmed">2761600</ArticleId></ArticleIdList></Reference><Reference><Citation>Portincasa P, Di Ciaula A, Palmieri V, Velardi A, vanBerge Henegouwen G, Palasciano G. Impaired gallbladder and gastric motility and pathological gastro-oesophageal reflux in gallstone patients. Eur J Clin Investig. 1997;27(8):653&#x2013;661. doi: 10.1046/j.1365-2362.1997.1600709.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2362.1997.1600709.x</ArticleId><ArticleId IdType="pubmed">9279528</ArticleId></ArticleIdList></Reference><Reference><Citation>Evenepoel P, Viaene L, Meijers B. Calcium balance in chronic kidney disease: walking the tightrope. Kidney Int. 2012;81(11):1057&#x2013;1059. doi: 10.1038/ki.2012.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.33</ArticleId><ArticleId IdType="pubmed">22584593</ArticleId></ArticleIdList></Reference><Reference><Citation>Derebey M, Y&#xfc;ksek Ma, Karabacak U, Mutlu V, Mizan SR, Tarim IA, et&#xa0;al. Effects of COVID-19 pandemic on management of acute cholecystitis: a single tertiary center&#x2019;s experience. J Exp Clin Med. 2022;39(1):164&#x2013;8.</Citation></Reference><Reference><Citation>Hilbrands Luuk B, Jager Kitty J, Noordzij Marlies Vart Priya Gansevoort Ron&#xa0;T, EWGDRFCFHMH. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87&#x2013;94. http://orcid.org/0000/0002-4935-9765</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771976</ArticleId><ArticleId IdType="pubmed">33340043</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolby T, Nafilyan V, Morgan A, Kallis C, Sheikh A, Quint JK. Relationship between asthma and severe COVID-19: a national cohort study. Thorax. 2023;78(2):120&#x2013;127. doi: 10.1136/thoraxjnl-2021-218629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218629</ArticleId><ArticleId IdType="pmc">PMC8983409</ArticleId><ArticleId IdType="pubmed">35354646</ArticleId></ArticleIdList></Reference><Reference><Citation>Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Risk of psoriasis in patients with childhood asthma: a Danish nationwide cohort study. Br J Dermatol. 2015;173(1):159&#x2013;164. doi: 10.1111/bjd.13781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.13781</ArticleId><ArticleId IdType="pubmed">25801416</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tallawy SN, Nalamasu R, Pergolizzi JV, Gharibo C. Pain management during the COVID-19 pandemic. Pain Ther. 2020;9:453&#x2013;466. doi: 10.1007/s40122-020-00190-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-020-00190-4</ArticleId><ArticleId IdType="pmc">PMC7445106</ArticleId><ArticleId IdType="pubmed">32840756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe8;s KF, Neufeld MY, Caron E, Sanchez SE, Brahmbhatt TS. COVID-19 pandemic and the cholecystitis experience at a major urban safety-net hospital. J Surg Res. 2021;264:117&#x2013;123. doi: 10.1016/j.jss.2021.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2021.02.037</ArticleId><ArticleId IdType="pmc">PMC7970019</ArticleId><ArticleId IdType="pubmed">33812090</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Schwarz PE, Perakakis N, Brajshori N, Beqiri P, Bornstein SR. The interface of COVID-19, diabetes, and depression. Discov Ment Health. 2022;2(1):5. doi: 10.1007/s44192-022-00007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44192-022-00007-0</ArticleId><ArticleId IdType="pmc">PMC8886346</ArticleId><ArticleId IdType="pubmed">35253006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavu A, Janzen D, Aboulatta L, Peymani P, Haidar L, Desrochers B, et al. Prescription trends of antiseizure medications before and during the COVID-19 pandemic. Front Neurol. 2023;14:1135962. doi: 10.3389/fneur.2023.1135962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1135962</ArticleId><ArticleId IdType="pmc">PMC10101333</ArticleId><ArticleId IdType="pubmed">37064207</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhayyat SS, Al-Kuraishy HM, Al-Gareeb AI, El-Bouseary MM, AboKamer AM, Batiha GES, et al. Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail. Inflamm Res. 2022;71(10&#x2013;11):1159&#x2013;1167. doi: 10.1007/s00011-022-01615-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01615-w</ArticleId><ArticleId IdType="pmc">PMC9360649</ArticleId><ArticleId IdType="pubmed">35941297</ArticleId></ArticleIdList></Reference><Reference><Citation>SHAP GitHub Repository. https://github.com/shap/shap/pull/3319. Accessed 13 Feb 2024.</Citation></Reference><Reference><Citation>Lau BHP, Tang CSK, Holroyd E, Wong WCW. Challenges and Implications for Menopausal Health and Help-Seeking Behaviors in Midlife Women From the United States and China in Light of the COVID-19 Pandemic: Web-Based Panel Surveys. JMIR Public Health Surveill. 2024;10:e46538. doi: 10.2196/46538.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/46538</ArticleId><ArticleId IdType="pmc">PMC10858418</ArticleId><ArticleId IdType="pubmed">38277194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mint S, Institute P. The Official Gazette of the Italian Republic: Approval of the National Statistical Program 2020-2022. Decree of the President of the Republic 9 March 2022. 2022. https://www.gazzettaufficiale.it/eli/gu/2022/05/26/122/so/20/sg/pdf. Accessed 27 May 2023.</Citation></Reference><Reference><Citation>Established Legislative Decree no. 322/1989 concerning National Statistical System organization the Sistan includes: the National Institute of Statistics (ISTAT); public bodies and statistical information bodies (INEA, ISFOL); the statistical offices of the State administrations and other public bodies, of the Government Offices of the Government, of the Regions and Autonomous Provinces, of the Provinces, of the Chambers of Commerce (CCIAA), of the Municipalities, single or associated, and the statistics offices of other public and private institutions that perform public interest functions. https://www.sistan.it/index.php?id=422. Accessed 6 June 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>